Ingredients

Urolithin A FAQ: Common Questions Answered

Written by ReCellence™ Editorial Team, Health Content SpecialistsReviewed by Medical Review Board, MD, PhDLast reviewed: March 7, 2026

Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.

What This Page Explains

Below are answers to frequently asked questions about Urolithin A, based on published clinical research and regulatory information. This page is for educational purposes only and does not constitute medical advice.

Scientists Call It 'The Hallmark of Aging.' We Call It Fixable.

Mitochondrial dysfunction is now recognized as a primary driver of aging. Here's the cellular renewal protocol that targets it directly.

Detailed Evidence

This FAQ covers the most common questions about Urolithin A — from what it is and how it works, to safety, dosage, and regulatory status. Each answer is grounded in published evidence and includes relevant citations. Frequently Asked Questions: What is Urolithin A? — A postbiotic produced by gut bacteria metabolizing ellagitannins from foods like pomegranates and walnuts. It activates mitophagy (mitochondrial recycling). Is Urolithin A safe? — Yes. It has FDA GRAS status (2018) and EFSA Novel Food approval (2022). No serious adverse events reported across multiple human trials at recommended doses. What dose of Urolithin A has been used in research? — Clinical trials used 250–2000 mg/day. 500 mg improved mitochondrial biomarkers; 1000 mg added muscle endurance and inflammatory benefits. Can I get Urolithin A from food? — Only indirectly. It is produced by gut bacteria from ellagitannins. Only ~40% of people (metabotype A) efficiently produce it; ~35% are non-producers. Who produces Urolithin A naturally? — People with sufficient Gordonibacter urolithinfaciens and Ellagibacter isourolithinifaciens gut bacteria — approximately 40% of the population. How long do I need to take Urolithin A to see effects? — The JAMA trial measured benefits at 4 months of daily supplementation. Consistent daily use appears important. What are the side effects of Urolithin A? — No serious adverse events reported. Mild, transient gastrointestinal discomfort has been reported rarely. Does Urolithin A interact with medications? — Urolithin A undergoes hepatic glucuronidation. Theoretical interactions with drugs affecting glucuronidation enzymes should be considered. Consult your healthcare provider. Who should avoid Urolithin A? — Pregnant/breastfeeding women (no safety data), children (no safety data), and individuals on multiple medications (consult physician). Is Urolithin A FDA approved? — It has FDA GRAS status (2018) — a safety designation, not drug approval. It is not FDA-approved to diagnose, treat, cure, or prevent any disease.

Evidence Hierarchy

Strongest

Systematic Reviews & Meta-Analyses

Multiple high-quality trials combined

Strong

Randomized Controlled Trials (RCTs)

Gold standard for treatment efficacy

Moderate

Observational Studies

Can show associations, not causation

Limited

Case Reports & Expert Opinion

Hypothesis-generating only

Weakest

Preclinical (Lab/Animal) Studies

Should NOT be extrapolated to humans

The $3.2 Billion Mistake the Supplement Industry Doesn't Want You to Know

They sell you antioxidants. You need mitochondrial support. There's a massive difference — and your energy levels prove it.

Study Quality Indicators

Higher Quality Indicators

  • Large sample size (hundreds to thousands)
  • Randomized and blinded design
  • Placebo-controlled comparison
  • Published in peer-reviewed journals
  • Replicated in multiple studies
  • Registered trial protocol before starting

Lower Quality Indicators

  • Small sample size (under 100)
  • No control group or blinding
  • Manufacturer-funded with conflicts
  • Only animal/cell studies
  • Never replicated
  • Published in predatory journals

Important Limitations

  • • Supplement research often has methodological limitations
  • • Results from one study may not generalize to all people
  • • Marketing claims often exceed what research supports
  • • Absence of evidence is not evidence of absence
  • • Individual response to supplements varies widely

Quick Answers

Q1.

What is the difference between Urolithin A and pomegranate extract?

They are distinct. Pomegranate provides ellagitannin precursors that gut bacteria must convert to Urolithin A (only ~40% of people do this efficiently). Urolithin A is the bioactive end metabolite produced by gut bacteria.

Q2.

Can Urolithin A replace exercise?

No. Exercise activates mitophagy through mechanisms overlapping with but distinct from UA's PINK1/Parkin pathway activation. Exercise has the strongest evidence base for health. UA should complement, not replace, exercise.

Q3.

How do I know if I'm producing Urolithin A naturally?

No consumer-grade test exists to determine individual Urolithin A production capacity (metabotype) as of 2026. Metabotype classification remains research-grade and requires specialized analysis.

Q4.

Is Urolithin A the same as ellagic acid?

No. Ellagic acid is the direct hydrolysis product of ellagitannins. Urolithin A is produced by further bacterial metabolism of ellagic acid. They are distinct compounds with different properties.

Q5.

Can I take Urolithin A with other supplements?

Yes. UA is often combined with fisetin (senolytic), spermidine (autophagy), and quercetin (senolytic/senomorphic). They target complementary aging pathways. Consult a healthcare provider for personalised advice.

Q6.

Is Urolithin A vegan?

Direct Urolithin A supplements are typically synthetic or bacterial-fermentation derived and vegan. Check individual product labels to confirm. Pomegranate-derived ellagitannins are also vegan.

Q7.

Does Urolithin A help with joint pain?

No clinical trial has studied Urolithin A for joint pain specifically. Anti-inflammatory biomarker reductions (CRP, IL-6, TNF-α) are secondary endpoints and cannot be extrapolated to clinical symptom relief.

Q8.

Is Urolithin A approved in Europe?

Yes. Urolithin A has EFSA Novel Food approval (EU, 2022) in addition to FDA GRAS status (US, 2018) — the two major Western regulatory frameworks.

Q9.

Can Urolithin A help with chronic fatigue?

The JAMA trial showed improved fatigue resistance at 1000 mg/day, consistent with improved mitochondrial function. No trial has specifically studied chronic fatigue syndrome. Consult a healthcare provider.

Q10.

Why is Urolithin A so expensive?

The cost reflects patented manufacturing, clinical trial investment (~$50M+), and regulatory filing costs across multiple jurisdictions. Mitopure® (Amazentis SA) is the only commercially available form with a substantial published clinical trial program.

Q11.

How should Urolithin A be stored?

Follow manufacturer instructions on the product label. Generally, store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Q12.

Can Urolithin A be applied topically?

Preclinical research on topical Urolithin A for skin aging exists, but no human clinical trials have been published. Topical UA is not an established application.

Q13.

Is Urolithin A regulated differently in different countries?

Yes. It has FDA GRAS status (US, 2018) and EFSA Novel Food approval (EU, 2022). Regulatory status varies by jurisdiction. Check local regulations in your country.

Q14.

What is the difference between Mitopure® and generic Urolithin A?

Mitopure® (Amazentis SA) is the only commercially available form with a substantial published clinical trial program. Generic UA supplements exist but may lack the purity, bioavailability, and clinical validation data of the patented form.

Q15.

Will my doctor know about Urolithin A?

Awareness varies. UA is a newer compound and some physicians may not be familiar with the research. Share the clinical evidence (JAMA Network Open, Cell Reports Medicine trials) and discuss whether it is appropriate for you.

Key Research Facts

1

Urolithin A and pomegranate extract are distinct: pomegranate provides ellagitannin precursors, while UA is the bioactive end metabolite produced by gut bacteria.

Strong Evidence

D'Amico et al., Trends in Molecular Medicine — doi:10.1016/j.molmed.2021.04.009

2

Exercise activates mitophagy through mechanisms overlapping with but distinct from UA's PINK1/Parkin pathway activation.

Strong Evidence

D'Amico et al., 2021 — doi:10.1016/j.molmed.2021.04.009

3

No consumer-grade test exists to determine individual Urolithin A production capacity (metabotype) as of 2026.

Strong Evidence

Espín et al., 2013 — doi:10.1155/2013/270418

4

Urolithin A has both FDA GRAS status (US, 2018) and EFSA Novel Food approval (EU, 2022), the two major Western regulatory frameworks.

Strong Evidence

FDA/EFSA — GRN 000833; EFSA-Q-2021-00513

5

Mitopure® (Amazentis SA) is the only commercially available form with a substantial published clinical trial program.

Strong Evidence

Amazentis SA publications — Multiple DOIs

6

No clinical trial has compared Urolithin A to exercise, other supplements, or pharmaceutical interventions for any outcome.

Strong Evidence

Jayatunga et al., 2024 — pubmed:39002645

7

Anti-inflammatory biomarker reductions (CRP, IL-6, TNF-α) are secondary endpoints — they cannot be extrapolated to clinical symptom relief.

Moderate Evidence

Liu et al., 2022; Zhu et al., 2024 — doi:10.1001/jamanetworkopen.2021.44279

8

Generic Urolithin A supplements exist but may lack the purity, bioavailability, and clinical validation data of the patented Mitopure® form.

Moderate Evidence

Industry analysis — Amazentis SA

9

Preclinical research on topical Urolithin A for skin aging exists, but no human clinical trials have been published.

Emerging Evidence

D'Amico et al., 2021 — doi:10.1016/j.molmed.2021.04.009

10

The supplement's cost reflects patented manufacturing, clinical trial investment (~$50M+), and regulatory filing costs across multiple jurisdictions.

Moderate Evidence

Industry analysis — Amazentis SA corporate data

Citations & External Resources

Clinical Registry

ClinicalTrials.gov — Search: Urolithin A

Regulatory

FDA GRAS Notice GRN 000833 — Urolithin A

Regulatory

EFSA Novel Food Catalogue — Urolithin A

Review

PubMed — Urolithin A research

Review

Nature Medicine — Ryu et al. 2016 (Landmark Study)

Review

JAMA Network Open — Liu et al. 2022 (Muscle Endurance RCT)

Institution

NIH Office of Dietary Supplements — Consumer Information

Review

Examine.com — Urolithin A Evidence Summary

Before You Spend Another Dollar on Supplements, Read This

Most supplements can't cross the mitochondrial membrane. ReCellence was designed specifically to reach where energy is made.

Related Reading

References (3)

Written by

ReCellence™ Editorial Team

Health Content Specialists

Medically reviewed by

Medical Review Board

MD, PhD

Last updated: March 8, 2026

Last medical review: March 8, 2026